Paraffin Immunoreactivity of CD10, CDw75, and Bcl-6 in Follicle Center Cell Lymphoma
- 1 January 2001
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 41 (5-6), 585-592
- https://doi.org/10.3109/10428190109060349
Abstract
Follicle center cell lymphoma(FCCL) has the following immunophenotype(IP): sIg+, Pan B+, CD10+/-, CD5-, CD23-/+, CD43-, CD11c-, CD25-. In addition, reactivities of a malignant lymphoma with CDw75(LN-1) and bcl-6 are considered indicators of FCCL. Bcl-6 expression is common in Grade 1 FCCL (100%) and rare in other indolent B-cell lymphomas(BCL). In contrast, bcl-2 expression is common in FCCL (80%) and in other BCL subtypes. Since no previous study has correlated paraffin immunoreactivity(PIR) of CD10, CDw75, and bcl-6 in FCCL (Grades 1–3), this is this study's purpose. Twenty-nine FCCL's were identified and reviewed (6, Grade 1; 10, Grade 2; 13, Grade 3) from the Division of Hematopathology, St. Louis University. The diagnoses were based on morphology and immunohistochemistry(IH)(21 cases) +/-the flow cytometric IP(14 cases). The paraffin blocks were stained for CD10 (Novacastra, Vector Laboratories, Burlingame, CA), CDw75 and bcl-6 (DAKO Corporation, Carpinteria, CA). Results showed that, CD10 by paraffin IH(PIH) was positive in 23 [18(strong); 3(moderate); 2(weak)] and negative in 6(3, Grade 2; 3, Grade 3). All CD10-cases were CDw75+; 4, bcl-6+. The two CD10-, bcl-6-cases were Grade 2. CDw75 was positive in 28 cases [16(strong); 11 (moderate); l(weak)] and negative in 1 (Grade 3; CD10+, bcl-2+, bcl-6+). Bcl-6 was positive in 26 [16(strong); 6(moderate); 4(weak)] and negative in 3(Grade 2's). Thus, the sensitivity of CD10, CDw75, and bcl-6 by PIH for FCCL was 79%, 97%, and 90%, respectively. Of the three stains evaluated by PIH in FCCL, CDw75 was the most sensitive, closely followed by bcl-6. CD10 was least sensitive-79%. By combining these 3 stains, the sensitivity was 100%; thus, a combined approach is recommended.Keywords
This publication has 8 references indexed in Scilit:
- CD10 and BCL-6 Expression in Paraffin Sections of Normal Lymphoid Tissue and B-Cell LymphomasThe American Journal of Surgical Pathology, 2000
- Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: Correlation with 3q27 and 18q21 chromosomal abnormalitiesHuman Pathology, 1999
- Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: Heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphomaHuman Pathology, 1999
- Bcl-6 Protein Expression by Follicle Center Lymphomas: A Marker for Differentiating Follicle Center Lymphomas From Other Low-Grade Lymphoproliferative DisordersAmerican Journal of Clinical Pathology, 1999
- Bcl-2 and bax protein expression in indolent versus aggressive B-cell non-hodgkin's lymphomasHuman Pathology, 1998
- BCL-6 EXPRESSION IN REACTIVE LYMPHOID TISSUE AND IN B-CELL NON-HODGKIN'S LYMPHOMASThe Journal of Pathology, 1996
- A Revised European-American Classification of Lymphoid Neoplasms Proposed by the International Lymphoma Study Group:A Summary VersionAmerican Journal of Clinical Pathology, 1995
- Expression in Non-Hodgkin's Lymphoma of thebcl-2 Protein Associated with the t(14;18) Chromosomal TranslocationNew England Journal of Medicine, 1988